Brain Fog and Fatigue in COVID Recovery
Brain fog and fatigue in COVID recovery have emerged as two of the most common and chronic symptoms of the illness.
A research study done between May and November 2020, found that Covid-19 “long haulers” experience prominent and persistent “brain fog” and fatigue that affect their cognition and quality of life. “Long haulers” are identified in this study as those who have Covid-19 related symptoms at least 6 weeks after their apparent recovery. The majority of subjects here had mild to moderate symptoms of Covid and never required Covid-related hospitalization.*
82% of hospitalized Covid patients have neurological symptoms and fatigue significant enough to affect quality of life. (Typical neurological problems include memory and attention impairments–often called “brain fog”). It is notable that in recovery from milder cases manageable without hospitalization, cognitive problems and significant fatigue also occur, and can significantly affect daily life.
Neurological issues contributing to ‘brain fog’ and chronic fatigue appear similar to those experienced by patients after mild traumatic brain injury and in those who have chronic fatigue syndrome.
At Abacus Chinese Medicine, Jeffrey creates herbal formulas for the various stages of COVID recovery support. He also compounds formulas that boost immunity for another line of preventative defense. You can read more about the stages of COVID support available from Abacus Chinese Medicine here.
You can also read more about Jeffrey’s unique Chinese herbal medicine practice that is unlike any other in our region here.
If you believe you have symptoms from Covid at any stage, Jeffrey can work with you to determine an immune boosting herbal formula appropriate for you. If you are unwell from an infectious condition, remote consultation is also available.
Make an appointment for an herbal consultation by texting:
(502) 299-8900 for new patients
(508) 237-3929 for established patients
Reference:
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. E. Graham, J. Clark, Z. Orban, P. Lim, et al. Annals of Clinical and Translational Neurology. 3/23/2021. https://doi.org/10.1002/acn3.51350
